The pharmaceutical industry is continuously evolving, with increasing demand for high-quality Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, is a key copyrightple of this trend. To meet this demand, US-based private label peptides manufacturing services are emerging. These companies offer a detailed suite of capabilities, f